Avantor (AVTR) Liabilities and Shareholders Equity (2018 - 2026)
Avantor's (AVTR) quarterly Liabilities and Shareholders Equity came in at $11.7 billion in Q1 2026, down 5.38% year-on-year from $12.3 billion in Q1 2025, and down 1.12% quarter-over-quarter from $11.8 billion in Q4 2025.
Avantor (AVTR) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends
Avantor's Liabilities and Shareholders Equity history runs 9 years deep, the most recent figure standing at $11.7 billion for Q1 2026.
- On a quarterly basis, Liabilities and Shareholders Equity fell 5.38% year-over-year to $11.7 billion in Q1 2026; TTM through Mar 2026 was $47.9 billion, a 4.13% decrease from a year earlier, with the FY2025 full-year figure at $11.8 billion, down 2.64% from the prior year.
- Liabilities and Shareholders Equity retreated to $11.7 billion in Q1 2026 per AVTR's latest filing, from $11.8 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $13.8 billion in Q1 2022 and bottomed at $5.3 billion in Q4 2022.
- The 5-year median for Liabilities and Shareholders Equity is $12.8 billion (2024), against an average of $11.9 billion.
- Across the five-year window, Liabilities and Shareholders Equity soared 103.38% in 2024 and fell 9.07% in 2025, its largest moves.
- Year by year, Liabilities and Shareholders Equity stood at $5.3 billion in 2022, then climbed by 13.4% to $6.0 billion in 2023, then surged by 103.38% to $12.1 billion in 2024, then slipped by 2.64% to $11.8 billion in 2025, then retreated by 1.12% to $11.7 billion in 2026.
- Per Business Quant, the three latest AVTR Liabilities and Shareholders Equity figures stand at $11.7 billion (Q1 2026), $11.8 billion (Q4 2025), and $11.7 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 20.88 Bn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | 50.83 Bn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 31.62 Bn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | 39.01 Bn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 8.78 Bn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 4.08 Bn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | 14.10 Bn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | 12.48 Bn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 6.31 Bn |
| 10 | Avantor | 8.00 Bn | 7.72 Bn | 500.70 Mn | 11.66 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.66 Bn |
| Dec 31, 2025 | 11.79 Bn |
| Sep 30, 2025 | 11.68 Bn |
| Jun 30, 2025 | 12.78 Bn |
| Mar 31, 2025 | 12.33 Bn |
| Dec 31, 2024 | 12.11 Bn |
| Sep 30, 2024 | 12.84 Bn |
| Jun 30, 2024 | 12.69 Bn |
| Mar 31, 2024 | 12.76 Bn |
| Dec 31, 2023 | 5.96 Bn |
| Sep 30, 2023 | 12.80 Bn |
| Jun 30, 2023 | 13.06 Bn |
| Mar 31, 2023 | 13.40 Bn |
| Dec 31, 2022 | 5.25 Bn |
| Sep 30, 2022 | 13.11 Bn |
| Jun 30, 2022 | 13.43 Bn |
| Mar 31, 2022 | 13.84 Bn |
| Dec 31, 2021 | 4.86 Bn |
| Sep 30, 2021 | 12.20 Bn |
| Jun 30, 2021 | 11.25 Bn |